Earnings calendar/STOK
Stoke Therapeutics, Inc. (STOK)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$-0.87
Street estimate
Revenue target
$7.7M
Street estimate
Trailing EPS (avg 4Q)
$-0.93
Beat rate last 4: 25%
Latest EPS YoY
-132.5%
vs 2025-08-12
Latest revenue YoY
-32.5%
How results look so far
Trailing revenue (avg 4Q)
$4.6M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 3, 2026
EPS miss
EPS actual / est
$-0.93 / $-0.80
-17.0%
Revenue actual / est
$9.3M / $4.9M
+90.7%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $-0.87 | Pending | — | $7.7M | Pending | — |
| 8/3/2026 | $-0.80 | $-0.93 | -17.0% | $4.9M | $9.3M | +90.7% |
| 5/12/2026upcoming | $-0.80 | Pending | — | $6.5M | Pending | — |
| 5/7/2026 | $-0.80 | $-0.79 | +1.3% | $6.5M | $6.2M | -3.9% |
| 3/24/2026 | $-0.93 | $-0.99 | -6.6% | $6.2M | $1.4M | -77.5% |
| 3/17/2026 | $-0.92 | $-0.99 | -8.1% | $6.2M | $1.4M | -77.5% |
| 3/16/2026 | $-0.75 | $-0.97 | -29.3% | $5.8M | $1.4M | -76.0% |
| 11/4/2025 | $-0.54 | $-0.65 | -20.4% | $4.6M | $10.6M | +133.4% |
| 8/12/2025 | $-0.57 | $-0.40 | +29.8% | $5.4M | $13.8M | +158.0% |
| 5/13/2025 | $-0.37 | $1.90 | +613.5% | $31.5M | $158.6M | +403.2% |
| 3/18/2025 | $-0.51 | $-0.18 | +64.7% | $3.9M | $22.6M | +485.9% |
| 11/5/2024 | $-0.52 | $-0.47 | +9.6% | $4.2M | $4.9M | +16.5% |
| 8/7/2024 | $-0.57 | $-0.46 | +19.3% | $3.3M | $4.8M | +48.2% |
| 5/6/2024 | $-0.60 | $-0.57 | +5.0% | $3.2M | $4.2M | +31.3% |
| 3/25/2024 | $-0.62 | $-0.60 | +3.2% | $3.3M | $2.8M | -13.8% |
| 11/7/2023 | $-0.65 | $-0.55 | +15.4% | $3.3M | $3.3M | +1.8% |
| 8/7/2023 | $-0.65 | $-0.69 | -6.2% | $3.2M | $2.5M | -21.7% |
| 5/4/2023 | $-0.70 | $-0.53 | +24.3% | $3.0M | $5.2M | +71.7% |
| 3/6/2023 | $-0.72 | $-0.65 | +9.7% | $2.9M | $3.3M | +14.2% |
| 11/14/2022 | $-0.69 | $-0.66 | +4.3% | $2.7M | $2.9M | +6.7% |
| 8/8/2022 | $-0.70 | $-0.63 | +10.0% | $2.6M | $3.2M | +22.4% |
| 5/10/2022 | $0.61 | $-0.66 | -208.2% | $50.0M | $3.0M | -94.0% |
| 3/10/2022 | $-0.62 | $-0.66 | -6.5% | — | Pending | — |
| 11/8/2021 | $-0.58 | $-0.61 | -5.2% | — | Pending | — |
| 8/10/2021 | $-0.49 | $-0.60 | -22.4% | — | Pending | — |
| 5/10/2021 | $-0.44 | $-0.46 | -4.5% | — | Pending | — |
| 3/9/2021 | $-0.43 | $-0.42 | +2.3% | — | Pending | — |
| 11/12/2020 | $-0.42 | $-0.41 | +2.4% | — | Pending | — |
| 8/10/2020 | $-0.36 | $-0.39 | -8.3% | — | Pending | — |
| 5/15/2020 | $-0.37 | $-0.34 | +8.1% | — | Pending | — |
| 2/24/2020 | $-0.31 | $-0.09 | +71.0% | — | Pending | — |
| 11/12/2019 | $-0.29 | $-0.26 | +10.3% | — | Pending | — |
| 8/14/2019 | $-0.96 | $-1.54 | -60.4% | — | Pending | — |
| 6/19/2019 | — | $-0.18 | — | — | Pending | — |
| 3/31/2019 | — | $-0.19 | — | — | Pending | — |
| 9/30/2018 | — | $-0.14 | — | — | Pending | — |
| 6/30/2018 | — | $-0.13 | — | — | Pending | — |
| 3/31/2018 | — | $-0.08 | — | — | Pending | — |